Globus Medical, Inc.

NYSE:GMED

Medical - Devices

Healthcare
$70.53 -2.71%

-$2.10 today

Market cap
$9.34B
Beta
0.95
P/E (TTM)
17.4
EPS (TTM)
$4.33
52W Low $51.79High $101.40

Volume 1.43M

Average 1.45M

GMED Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Globus Medical, Inc.NYSE: GMED

Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026

Cash & equivalents rises 121.3% from a year ago

Cash & equivalents stood at $507.75M at the end of Q2 FY2026, up 121.3% from a year earlier and down 9.5% from the prior quarter. Over 3 fiscal years it compounded at +51.8% a year.

Context

  • Cash & equivalents amounted to 9.3% of total assets at the end of Q2 FY2026, up 4.6 pp from a year earlier.
  • Cash & equivalents increased in 2 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +121.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$507.75M-9.5% QoQ
Last fiscal yearDec 2025
$526.16M-32.9% YoY
Year agoJun 2025
$229.45M+121.3% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+121.3%——
1 year-32.9%——
3-year CAGR+51.8%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
526.16M USD
Year-over-year change
-32.9%
4-year CAGR
+28.5%

Cash & Equivalents vs competitors

How GMED compares with its peers on the latest reported figures

  • GMED's Jun 2026 cash & equivalents of $507.75M is the 3rd highest of the 10 companies compared; the peer median is $120.28M.
  • Its year-over-year change of +121.3% is the 2nd highest of 10, against a peer median of -8.7%.
  • Cash & equivalents amounts to 9.3% of total assets for GMED, versus a peer median of 7.1%.
GMED Competitors Peer median
Cash & Equivalents for GMED and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SYKStryker CorporationJun 2026$3.39B +42.8%+29.6%7.1%
SNNSmith & Nephew plcDec 2025$557M -10.0%+16.8%5.3%
GMEDGlobus Medical, Inc.Jun 2026$507.75M +121.3%+51.8%9.3%
ZBHZimmer Biomet Holdings, Inc.Jun 2026$410M -26.4%+16.4%1.8%
ATECAlphatec Holdings, Inc.Mar 2026$139.91M -8.7%+23.8%17.5%
OFIXOrthofix Medical Inc.Mar 2026$120.28M +107.5%+17.4%13.6%
BVSBioventus Inc.Mar 2026$35.85M +57.2%+19.3%5.5%
SIBNSI-BONE, Inc.Mar 2026$33.54M -18.6%+26.8%13.8%
KIDSOrthoPediatrics Corp.Mar 2026$14.25M -57.4%+29.6%2.8%
XTNTXtant Medical Holdings, Inc.Mar 2026$12.16M +141.6%-5.6%15.6%
Peer median (excluding GMED) $120.28M-8.7%+19.3%7.1%

Competitors are the stored peer set for GMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents193.07M150.47M467.29M784.44M526.16M
Short-term Investments250.38M295.59M50.5M105.62M31.09M
Net Receivables165.65M217.31M504.87M578.33M743.67M
Inventory237M298.98M848.14M659.23M759.28M
Other Current Assets021M44.58M49.64M65.43M
Total Current Assets864.52M983.34M1.92B2.18B2.13B
Property, Plant & Equipment (Net)221.08M243.73M646.86M611.56M628.24M
Goodwill179.71M197.47M1.43B1.43B1.44B
Intangible Assets68.66M63.57M924.6M795.12M745.06M
Long-term Investments562.48M495.85M75.43M66.13M71.82M
Tax Assets24.49M48.85M10.69M94.2M218.22M
Other Non-current Assets36.33M43.31M78.59M75.1M78.78M
Total Non-current Assets1.09B1.09B3.17B3.07B3.18B
Total Assets1.96B2.08B5.09B5.25B5.3B
Account Payables21.96M36.1M56.67M75.12M98.85M
Short-term Debt000443.35M0
Tax Payables7.46M11.02M27.57M44.81M4.16M
Deferred Revenue12.03M14.1M18.37M22.14M27.66M
Other Current Liabilities64.18M66.66M201.85M185.56M186.62M
Total Current Liabilities140.16M159.2M392.35M855.91M498.5M
Long-term Debt00417.4M0103.92M
Deferred Tax Liabilities4.31M1.78M84.42M23.89M23.76M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities71.4M65.3M102.92M111.03M103.34M
Total Non-current Liabilities75.71M70.55M695.78M218.5M231.01M
Total Liabilities215.88M229.75M1.09B1.07B729.51M
Common Stock101K100K136K137K135K
Retained Earnings1.19B1.24B1.14B1.15B1.39B
Accumulated OCI(6.77M)(24.63M)(10.19M)(6.86M)15.35M
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.74B1.85B4B4.18B4.57B
Total Debt06.01M520.4M537.19M118.66M
Net Debt(193.07M)(144.46M)53.11M(247.25M)(407.5M)

Globus Medical, Inc.

NYSE:GMED

Intrinsic Alpha fair value

Locked

Current Price

$70.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.